| |
Report |
Presentation |
Webcast |
|
December 9, 2020
Interim Report May – October 2020 – Report
|
|
|
|
|
December 3, 2020
Oasmia’s Partner Elevar Provides an Update on Apealea Development Plans in Ovarian Cancer
|
|
|
|
|
November 11, 2020
Investival Showcase 11-16 November 2020, Virtual Conference
|
|
|
|
|
29 October, 2020
BIO-Europe®, Virtual Conference
|
|
|
|
|
October 7, 2020
Oasmia Erik Penser Cancer Day Presentation
|
|
|
|
|
September 24, 2020
Oasmia Erik Penser Investor Event Presentation
|
|
|
|
|
September 21, 2020
Presentation at Sachs Biotech in Europe Forum
|
|
|
|
|
September 15, 2020
Aktiedagen Digitalt
|
|
|
|
|
September 9, 2020
Interim Report May – July 2020
|
|
|
|
|
August 19, 2020
Annual Report 2019 / 2020
|
|
|
|
|
July 30, 2020
Analysguiden: Interview with Oasmia
|
|
|
|
|
June 18, 2020
Year-end Report 2019 / 2020
|
|
|
|
|
June 10, 2020
Company Presentation Aktiespararna
|
|
|
|
|
June 3, 2020
Avanza Börsdag
|
|
|
|
|
May 13, 2020
Strategic Review Presentation
|
|
|
|
|
March 27, 2020
Interim Report May 2019 – January 2020
|
|
|
|
|
March 25, 2020
Elevar deal
|
|
|
|
|
February 14, 2020
Oasmia appoints new CEO
|
|
|
|
